Intestinal Protozoa

Published on 08/02/2015 by admin

Filed under Basic Science

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 7912 times

Intestinal Protozoa

The protozoa are unicellular eukaryotic organisms, most of which are microscopic. They have a number of specialized organelles that are responsible for life functions and that allow further division of the group into classes. Most protozoa multiply by binary fission and are ubiquitous worldwide.

The important characteristics of the intestinal protozoa are presented in Tables 48-1 to 48-7. The clinically relevant intestinal protozoa are generally considered to be Entamoeba histolytica, Blastocystis hominis, Giardia lamblia, Dientamoeba fragilis, Balantidium coli, Isospora (Cystoisospora) belli, Cryptosporidium spp., Cyclospora cayetanensis, and the microsporidia. Nonpathogenic intestinal protozoa are listed in various figures and tables but are not discussed in detail.

TABLE 48-1

Intestinal Protozoa: Trophozoites of Common Amebae

Characteristic Entamoeba histolytica Entamoeba dispar Entamoeba hartmanni Entamoeba coli Endolimax nana Iodamoeba bütschlii
Size* (diameter or length) 12-60 µm (usual range, 15-20 µm); invasive forms may be > 20 µm Same size range as E. histolytica 5-12 µm (usual range, 8-10 µm) 15-50 µm (usual range, 20-25 µm) 6-12 µm (usual range, 8-10 µm) 8-20 µm (usual range, 12-15 µm)
Motility Progressive, with hyaline, finger-like pseudopodia; motility may be rapid Same motility as E. histolytica Usually nonprogressive Sluggish, nondirectional; blunt, granular pseudopodia Sluggish, usually nonprogressive Sluggish, usually nonprogressive
Nucleus (single) and visibility Difficult to see in unstained preparations Difficult to see in unstained preparations Usually not seen in unstained preparations Often visible in unstained preparation Occasionally visible in unstained preparations Usually not visible in unstained preparations
Peripheral chromatin (stained) Fine granules, uniform in size and usually evenly distributed; may have beaded appearance Fine granules, uniform in size and usually evenly distributed; may have beaded appearance Nucleus may stain more darkly than in E. histolytica, although morphology is similar; chromatin may appear as solid ring rather than beaded (trichrome) May be clumped and unevenly arranged on the membrane; may also appear as solid, dark ring with no beads or clumps Usually no peripheral chromatin; nuclear chromatin may be quite variable Usually no peripheral chromatin
Karyosome (stained) Small, usually compact; centrally located but may also be eccentric Small, usually compact; centrally located but may also be eccentric Usually small and compact; may be centrally located or eccentric Large, not compact; may or may not be eccentric; may be diffuse and darkly stained Large, irregularly shaped; may appear blotlike; many nuclear variations are common; may mimic E. hartmanni or Dientamoeba fragilis Large, may be surrounded by refractile granules that are difficult to see (“basket nucleus”)
Cytoplasm appearance (stained) Finely granular, “ground glass” appearance; clear differentiation of ectoplasm and endoplasm; if present, vacuoles are usually small Finely granular, “ground glass” appearance; clear differentiation of ectoplasm and endoplasm; if present, vacuoles are usually small Finely granular Granular, with little differentiation into ectoplasm and endoplasm; usually vacuolated Granular, vacuolated Granular, may be heavily vacuolated
Inclusions (stained) Noninvasive organism may contain bacteria; presence of red blood cells (RBCs) is diagnostic; presence of RBCs is the only characteristic that allows differentiation between pathogenic E. histolytica and nonpathogenic E. dispar Organisms usually contain bacteria; RBCs not present in cytoplasm May contain bacteria; no RBCs Bacteria, yeast, other debris Bacteria Bacteria

image

*These sizes refer to wet preparation measurements. Organisms on a permanent stained smear may be 1 to 1.5 µm smaller as a result of artificial shrinkage.

TABLE 48-2

Intestinal Protozoa—Cysts of Common Amebae

Characteristic Entamoeba Histolytica/Entamoeba dispar Entamoeba hartmanni Entamoeba coli Endolimax nana Iodamoeba bütschlii
Size* (diameter or length) 10-20 µm (usual range, 12-15 µm) 5-10 µm (usual range, 6-8 µm) 10-35 µm (usual range, 15-25 µm) 5-10 µm (usual range, 6-8 µm) 5-20 µm (usual range, 10-12 µm)
Shape Usually spherical Usually spherical Usually spherical; may be oval, triangular, or other shapes; may be distorted on permanent stained slide because of inadequate fixative penetration Usually oval, may be round May vary from oval to round; cyst may collapse because of large glycogen vacuole space
Nucleus (number and visibility) Mature cyst: 4 nuclei
Immature cyst: 1-2 nuclei; nuclear characteristics difficult to see on wet preparation
Mature cyst: 4 nuclei; Immature cyst: 1-2 nuclei (2-nucleated cysts very common) Mature cyst: 8 (occasionally 16 or more nuclei may be seen) Immature cysts with 2 or more nuclei are occasionally seen Mature cyst: 4 Immature cysts: 2 Very rarely seen and may resemble cysts of Enteromonas hominis Mature cyst: 1
Peripheral chromatin (stained) Peripheral chromatin present; fine, uniform granules, evenly distributed; nuclear characteristics may not be as clearly visible as in trophozoite Fine granules evenly distributed on the membrane; nuclear characteristics may be difficult to see Coarsely granular; may be clumped and unevenly arranged on membrane; nuclear characteristics not as clearly defined as in trophozoite; may resemble E. histolytica No peripheral chromatin No peripheral chromatin
Karyosome (stained) Small, compact, usually centrally located but occasionally may be eccentric Small, compact, usually centrally located Large, may or may not be compact and/or eccentric; occasionally may be centrally located Smaller than karyosome seen in trophozoites but generally larger than those of genus Entamoeba Larger, usually eccentric refractile granules may be on one side of karyosome (“basket nucleus”)
Cytoplasm, chromatoidal bodies (stained) May be present; bodies usually elongate, with blunt, rounded, smooth edges; may be round or oval Usually present; bodies usually elongate with blunt, rounded, smooth edges; may be round or oval May be present (less frequently than in E. histolytica); splinter shaped with rough, pointed ends Rare chromatoidal bodies present; occasionally small granules or inclusions seen; fine linear chromatoidals may be faintly visible on well-stained smears No chromatoidal bodies present; occasionally small granules may be present
Glycogen (stained with iodine) May be diffuse or absent in mature cyst; clumped chromatin mass may be present in early cysts (stains reddish brown with iodine) May or may not be present, as in E. histolytica May be diffuse or absent in mature cyst; clumped mass occasionally seen in mature cysts (stains reddish brown with iodine) Usually diffuse if present (stains reddish brown with iodine) Large, compact, well-defined mass (stains reddish brown with iodine)

image

*Wet preparation measurements; in permanent stains, organisms usually are 1 to 2 µm smaller.

TABLE 48-3

Intestinal Protozoa—Trophozoites of Flagellates

Protozoa Shape and Size Motility Number of Nuclei and Visibility Number of Flagella (Usually Difficult to See) Other Features
Dientamoeba fragilis Shaped like amebae; 5-15 µm (usual range, 9-12 µm) Usually nonprogressive; pseudopodia are angular, serrated, or broad lobed and almost transparent Percentage may vary, but 40% of organisms have 1 nucleus and 60% have 2 nuclei; not visible in unstained preparations; no peripheral chromatin; karyosome is composed of a cluster of 4-8 granules Internal flagella; not visible Cytoplasm finely granular and may be vacuolated with ingested bacteria, yeasts, and other debris; may be great variation in size and shape on a single smear
Giardia lamblia Pear-shaped; length 10-20 µm; width, 5-15 µm “Falling leaf” motility may be difficult to see if organism is in mucus; slight flutter of flagella may be visible using low light (duodenal aspirate or mucus from Entero-Test capsule) 2; not visible in unstained mounts 4 lateral; 2 ventral, 2 caudal Sucking disk occupies one half to three fourths of ventral surface; pear-shaped front view, spoon-shaped side view
Chilomastix mesnili Pear-shaped; length 6-24 µm (usual range, 10-15 µm); width, 4-8 µm Stiff, rotary 1; not visible in unstained mounts 3 anterior, 1 in cytostome Prominent cytostome extending one third to one half the length of the body; spiral groove across ventral surface
Pentatrichomonas hominis Pear-shaped; length 5-15 µm (usual range, 7-9 µm); width 7-10 µm Jerky, rapid 1; not visible in unstained mounts 3-5 anterior, 1 posterior Undulating membrane extends the length of the body; posterior flagellum extends free beyond end of body
Trichomonas tenax Pear shaped; length 5-12 µm; average of 6.5-7.5 µm; width, 7-9 µm Jerky, rapid 1; not visible in unstained mounts 4 anterior, 1 posterior Seen only in preparations from mouth; axostyle (slender rod) protrudes beyond the posterior end and may be visible; posterior flagellum extends only halfway down the body; no free end
Enteromonas hominis Oval; 4-10 µm (usual range, 8-9 µm); width, 5-6 µm Jerky 1; not visible in unstained mounts 3 anterior, 1 posterior One side of the body is flattened; posterior flagellum extends free posteriorly or laterally
Retortamonas intestinalis Pear-shaped or oval; 4-9 µm (usual range, 6-7 µm); width, 3-4 µm Jerky 1; not visible in unstained mount 1 anterior, 1 posterior Prominent cytostome extends approximately one half the length of the body

image

TABLE 48-4

Intestinal Protozoa—Cysts of Flagellates

Protozoa Size Shape Number of Nuclei Other Features
Dientamoeba fragilis, Pentatrichomonas hominis, Trichomonas tenax No cyst stage      
Giardia lamblia 8-19 µm (usual range, 11-14 µm); width, 7-10 µm Oval, ellipsoidal, or may appear round 4; not distinct in unstained preparations; usually located at one end Longitudinal fibers in cysts may be visible in unstained preparations; deep staining median bodies usually lie across the longitudinal fibers. Shrinkage is common, with the cytoplasm pulling away from the cyst wall; “halo” effect may be seen around the outside of the cyst wall because of shrinkage caused by dehydrating reagents
Chilomastix mesnili 6-10 µm (usual range, 7-9 µm); width, 4-6 µm Lemon or pear shaped with anterior hyaline knob 1; not distinct in unstained preparations Cytostome with supporting fibrils, usually visible in stained preparation; curved fibril along side of cytostome, usually referred to as a “shepherd’s crook”
Enteromonas hominis 4-10 µm (usual range, 6-8 µm); width, 4-6 µm Elongate or oval 1-4; usually 2 lying at opposite ends of cyst; not visible in unstained mounts Resembles Endolimax nana cyst; fibrils or flagella usually not seen
Retortamonas intestinalis 4-9 µm (usual range, 4-7 µm); width, 5 µm Pear shaped or slightly lemon shaped 1; not visible in unstained mounts Resembles Chilomastix cyst; shadow outline of cytostome with supporting fibrils extends above nucleus; “bird beak” fibril arrangement

image

TABLE 48-5

Intestinal Protozoa—Ciliates

Protozoa Shape and Size Motility Number of Nuclei Other Features
Balantidium coli
trophozoite
Ovoid with tapering anterior end; 50-100 µm long, 40-70 µm wide (usual range, 40-50 µm) Ciliates: rotary, boring; may be rapid 1 large kidney-shaped macronucleus; 1 small round micronucleus, which is difficult to see even in stained smear; macronucleus may be visible in unstained preparation Body covered with cilia, which tend to be longer near cytostome; cytoplasm may be vacuolated
Cyst Spherical or oval; 50-70 µm (usual range, 50-55 µm)   1 large macronucleus visible in unstained preparation; micronucleus difficult to see Macronucleus and contractile vacuole are visible in young cysts; in older cysts, internal structure appears granular; cilia difficult to see in cyst wall

image

TABLE 48-6

Morphologic Criteria Used to Identify Intestinal Protozoa (Coccidia, Blastocystis hominis)

Protozoa Shape and Size Other Features
Cryptosporidium spp.
 C. parvum (humans and animals)
 C. hominis (humans)
Oocyst generally round, 4-6 µm; each mature oocyst contains four sporozoites Oocyst, diagnostic stage in stool, sporozoites occasionally visible within oocyst wall; acid-fast positive using modified acid-fast stains; various other stages in life cycle can be seen in biopsy specimens taken from gastrointestinal tract (brush border of epithelial cells) and other tissues; disseminated infection well documented in compromised host; oocysts immediately infective (in both formed and/or watery specimens); nosocomial infections documented; use enteric precautions for inpatients.
Cyclospora cayetanensis Oocyst generally round, 8-10 µm; oocysts are not mature, no visible internal structure; oocysts may appear wrinkled Oocyst, diagnostic stage in stool; acid-fast variable using modified acid-fast stains; color range from clear to deep purple (tremendous variation); best results obtained with decolorizing solution consisting of 1% acid, 3% maximum; oocysts may appear wrinkled (like crumpled cellophane); mimic Cryptosporidium oocysts but are twice as large.
Isospora (Cystoisospora) belli Ellipsoidal oocyst; range 20-30 µm long, 10-19 µm wide; sporocysts rarely seen broken out of oocysts but measure 9-11µm Mature oocyst contains two sporocysts with four sporozoites each; usual diagnostic stage in feces is immature oocyst containing spherical mass of protoplasm (intestinal tract). Oocysts are modified acid-fast positive. Whole oocyst may stain pink, but just the internal sporocysts stain if the oocyst is mature.
Sarcocystis hominis
S. suihominis
S. bovihominis
Oocyst thin-walled and contains two mature sporocysts, each containing four sporozoites; frequently thin oocyst wall ruptures; ovoid sporocysts each measure 10-16 µm long and 7.5-12 µm wide Thin-walled oocyst or ovoid sporocysts occur in stool (intestinal tract)
S. “lindemanni” Shapes and sizes of skeletal and cardiac muscle sarcocysts vary considerably Sarcocysts contain several hundred to several thousand trophozoites, each measuring 12-16µm long and 4-9µm wide. Sarcocysts may also be divided into compartments by septa, which are not seen in Toxoplasma cysts (tissue/muscle).
Blastocystis hominis Organisms are generally round, measure approximately 6-40 µm, and are usually characterized by a large, central body (looks like a large vacuole); this stage has been called the central body form The more amebic form can be seen in diarrheal fluid but is difficult to identify. The central body forms vary tremendously in size, even on a single fecal smear; this is the most common form seen. Routine fecal examinations may indicate a positive rate much higher than other protozoa; some laboratories report figures of 20% and higher.

TABLE 48-7

Microsporidia That Cause Human Infection

Microsporidia Immunocompromised Patient Immunocompetent Patient Comments
Common      
Enterocytozoon bieneusi Chronic diarrhea; wasting syndrome, cholangitis, acalculous cholecystitis, chronic sinusitis, chronic cough, pneumonitis; cause of diarrhea in organ transplant recipients Self-limiting diarrhea in adults and children; traveler’s diarrhea; asymptomatic carriers Short-term culture only; three strains identified but not named; AIDS patients with chronic diarrhea (present in 5% to 30% of patients when CD4 lymphocyte counts are very low); pigs, nonhuman primates
Encephalitozoon hellem Disseminated infection; keratoconjunctivitis; sinusitis, bronchitis, pneumonia, nephritis, ureteritis, cystitis, prostatitis, urethritis Possibly diarrhea Cultured in vitro; detected in people with traveler’s diarrhea and co-infection with E. bieneusi; pathogenicity unclear; spores not reported yet from stool; psittacine birds
Encephalitozoon intestinalis Chronic diarrhea, cholangiopathy; sinusitis, bronchitis, pneumonitis; nephritis, bone infection, nodular cutaneous lesions Self-limiting diarrhea; asymptomatic carriers Cultured in vitro; formerly Septata intestinalis; AIDS patients with chronic diarrhea; dogs, donkeys, pigs, cows, goats
Encephalitozoon cuniculi Disseminated infection; keratoconjunctivitis, sinusitis, bronchitis, pneumonia; nephritis; hepatitis, peritonitis, symptomatic and asymptomatic intestinal infection; encephalitis Not described. Two HIV-serologically negative children with seizure disorder (suspect E. cuniculi infection) presumably were immunocompromised Cultured in vitro; wide mammalian host range
Uncommon      
Pleistophora sp. Myositis (skeletal muscle) Not described Tend to infect fish
Pleistophora ronneafiei Myositis Not described  
Trachipleistophora hominis Myositis; myocarditis keratoconjunctivitis; sinusitis Keratitis Cultured in vitro; AIDS patients
Trachipleistophora anthropophthera Disseminated infection; keratitis Not described AIDS patients
Anncaliia connori Disseminated infection Not described (Formerly Nosema connori); often infects insects; disseminated in infant with SCID
Anncaliia vesicularum Myositis Not described Formerly Brachiola vesicularum
Anncaliia algerae Myositis; nodular cutaneous lesions Keratitis (Formerly Nosema algerae or Brachiola algerae); cultured in vitro; skin nodules in boy with acute lymphocytic leukemia; found in arthropods
Nosema ocularum Not described Keratitis HIV–serologically negative individual
Vittaforma corneae Disseminated infection; urinary tract infection Keratitis (Formerly Nosema corneum); cultured in vitro; non-HIV patient
Microsporidium ceylonensis* Not described Corneal ulcer, keratitis HIV–serologically negative individual, autopsy
Microsporidium africanum* Not described Corneal ulcer, keratitis HIV–serologically negative individual, autopsy
Microsporidia (not classified)   Keratoconjunctivitis in a contact lens wearer  

image

AIDS, Acquired immunodeficiency syndrome; HIV, human immunodeficiency virus; SCID, severe combined immunodeficiency

*Microsporidium is a collective generic name for microsporidia that cannot be classified

Amebae

The class Sarcodina, or Amebae, includes the organisms capable of movement by means of cytoplasmic protrusions called pseudopodia. This group includes free-living organisms, in addition to nonpathogenic and pathogenic organisms found in the intestinal tract and other areas of the body (see Tables 48-1 and 48-2). Occasionally, when fresh stool material is examined as a direct wet mount, motile trophozoites may be seen, as well as other, nonparasitic structures (Figure 48-1).

Entamoeba histolytica

General Characteristics

Living trophozoites (motile feeding stage) of E. histolytica vary in size from about 12 to 60 µm in diameter. Organisms recovered from diarrheic or dysenteric stools generally are larger than those in formed stool from an asymptomatic individual. The motility has been described as rapid and unidirectional. Although this characteristic motility is often described, amebiasis rarely is diagnosed on the basis of motility seen in a direct mount. The cytoplasm is differentiated into a clear outer ectoplasm and a more granular inner endoplasm.

E. histolytica has directional and progressive motility, whereas the other amebae tend to move more slowly and at random. However, motility is rarely seen even in a fresh wet mount from a patient with diarrhea or dysentery. The cytoplasm is generally more finely granular, and the presence of red blood cells (RBCs) in the cytoplasm is considered diagnostic for E. histolytica (Figure 48-2).

Permanent stained smears demonstrate accurate morphology compared with other techniques. When the organism is examined on a permanent stained smear (trichrome or iron-hematoxylin stain), the morphologic characteristics of E. histolytica/E. dispar are readily seen. The nucleus is characterized by evenly arranged chromatin on the nuclear membrane and a small, compact, centrally located karyosome (condensed chromatin). As mentioned, the cytoplasm usually is described as finely granular, with few ingested bacteria and scant debris in vacuoles. As stated previously, in organisms isolated from a patient with dysentery, RBCs may be visible in the cytoplasm, a feature diagnostic for E. histolytica (Figure 48-3). Most often, infection with E. histolytica is diagnosed on the basis of the organism’s morphology, without the presence of RBCs.

As part of the life cycle, the trophozoites may condense into a round mass (precyst), and a thin wall is secreted around the immature cyst. Two types of inclusions may be found in this immature cyst: a glycogen mass and highly refractile chromatoidal bars (refractile chromatin structure) with smooth, rounded edges. As the cyst matures (metacyst) (see Figure 48-3; Figure 48-4), nuclear division occurs, with the production of four nuclei. Often chromatoidals may be absent in the mature cyst. Cyst morphology does not differentiate E. histolytica from E. dispar. Cyst formation occurs only in the intestinal tract; once the stool has left the body, cyst formation does not occur. The one-, two-, and four-nucleated cysts are infective and represent the mode of transmission from one host to another.

Epidemiology

Amebiasis is caused by infection with the true pathogen, Entamoeba histolytica. Recent evidence from molecular studies confirms the differentiation of pathogenic E. histolytica and nonpathogenic E. dispar (Figure 48-5) as two distinct species. E. histolytica is considered the etiologic agent of amebic colitis and extraintestinal abscesses (amebic liver abscess), whereas nonpathogenic E. dispar produces no intestinal symptoms and is not invasive in humans.

Infection is acquired through the fecal-oral route from infective cysts contained in the feces. These cysts can be ingested in contaminated food or drink or contracted from fomites or various sexual practices that could include accidental ingestion of fecal organisms. Flies and cockroaches have been implicated as mechanical vectors of contaminated fecal material.

The infection occurs worldwide, particularly in areas with poor sanitation. It is estimated that E. histolytica infection kills more than 100,000 people each year.

Pathogenesis and Spectrum of Disease

The pathogenesis of E. histolytica is related to the organism’s ability to directly lyse host cells and cause tissue destruction. Amebic lesions show evidence of cell lysis, tissue necrosis, and damage to the extracellular matrix. Evidence indicates that E. histolytica trophozoites interact with the host through a series of steps: adhesion to the target cell, phagocytosis, and cytopathic effect. Numerous other parasite factors also play a role. From the perspective of the host, E. histolytica induces both humoral and cellular immune responses; cell-mediated immunity is the major human host defense against this complement-resistant cytolytic protozoan.

The presentations of disease are seen with invasion of the intestinal mucosa or dissemination to other organs (most often the liver) or both. However, it is estimated that a small proportion (2% to 8%) of infected individuals have invasive disease beyond the lumen of the bowel. Also, organisms may be spontaneously eliminated with no disease symptoms.

Asymptomatic Infection.

Individuals harboring E. histolytica may have either a negative or a weak antibody titer and negative stools for occult blood. They also may be passing cysts detectable by a routine ova and parasite (O&P) examination. However, these cysts cannot be morphologically differentiated from those of the nonpathogen, E. dispar. Although trophozoites may be identified, they will not contain any phagocytized RBCs and cannot be differentiated from E. dispar. Molecular analyses of organisms isolated from asymptomatic individuals generally indicate that the isolates belong to the nonpathogenic E. dispar. Generally, asymptomatic patients never become symptomatic and may excrete cysts for a short period. This pattern is seen in patients infected with either nonpathogenic or pathogenic organisms.

Intestinal Disease.

The incubation period varies from a few days to a much longer time; in an area where E. histolytica is endemic, it is impossible to determine exactly when exposure to the organism occurred. Normally, the incubation time ranges from 1 to 4 weeks. Although the exact mode of mucosal penetration is not known, microscopic studies suggest that amebae have enzymes that lyse. The enzymes are released from lysosomes on the surface of the amebae or from enzymes in the tissue released from ruptured organisms. Amebic ulcers often develop released the cecum, appendix, or adjacent portion of the ascending colon; however, they can also be found in the sigmoidorectal area. Other lesions may occur from these primary sites. Ulcers usually are raised, with a small opening on the mucosal surface and a larger area of destruction below the surface (i.e., flask shaped). The mucosal lining may appear normal between ulcers.

Invasive intestinal amebiasis has four clinical forms, all of which are generally acute: dysentery (bloody diarrhea), fulminating colitis, amebic appendicitis, and ameboma of the colon. Dysentery and diarrhea account for 90% of cases of invasive intestinal amebiasis. The severity of symptoms can range from asymptomatic to severe symptoms that mimic ulcerative colitis. Patients with colicky abdominal pain, frequent bowel movements, and tenesmus (a persistent feeling of needing to pass stool) may present with a gradual onset of disease. With the onset of dysentery, bowel movements are frequent (up to 10 per day). Although dysentery may last for months, it varies from severe to mild and may lead to weight loss and prostration. In severe cases, symptoms may begin very suddenly and include profuse diarrhea, fever, and dehydration with electrolyte imbalances.

Hepatic Disease.

Blood flow from the mesenteric veins surrounding the intestine returns blood, via the portal vein, to the liver, most commonly the upper right lobe. Amebae in the submucosa can be carried by the bloodstream to the liver. The onset of symptoms may be gradual or sudden; upper right abdominal pain and fever (38° to 39°C) are the most consistent findings. Although the liver may be enlarged and tender, liver function tests may be normal or slightly abnormal (jaundice is rare). The abscess can be visualized radiologically, sonically, or by radionuclear scan; most patients have a single abscess in the right lobe of the liver. The most common complication is rupture of the abscess into the pleural space. An abscess also can extend into the peritoneum and through the skin. Hematogenous spread to the brain, lung, pericardium, and other sites is possible.

Pyogenic and amebic liver abscesses are the two most common hepatic abscesses. The severity of a pyogenic abscess depends on the bacterial source and the patient’s underlying condition. An amebic abscess tends to be more prevalent in those with suppressed cell-mediated immunity, men, and younger individuals. E. histolytica cysts and trophozoites are found in the stools of only a few patients with liver abscess. About 60% of these patients have no intestinal symptoms or any history of dysentery.

Laboratory Diagnosis

Routine Methods.

The standard O&P examination is the recommended procedure for recovery and identification of E. histolytica in stool specimens. Microscopic examination of a direct saline wet mount may reveal motile trophozoites, which may contain RBCs. However, trophozoites with RBCs are found only in a limited number of cases. In many patients who do not present with acute dysentery, trophozoites may be present but do not contain RBCs, and the organisms may be pathogenic E. histolytica or nonpathogenic E. dispar. An asymptomatic individual may have few trophozoites and possibly only cysts in the stool. Although the concentration technique is helpful for demonstrating cysts, the most important technique for the recovery and identification of protozoan organisms is the permanent stained smear (normally stained with trichrome or iron-hematoxylin). A minimum of three specimens collected over not more than 10 days may be required for identification.

Sigmoidoscopy specimens may be very helpful for identifying organisms. At least six areas of the mucosa should be sampled. Smears from these areas should be examined after permanent staining. However, these specimens are not considered a substitute for the recommended minimum of three stool specimens submitted for O&P examination (direct, concentration, and permanent stained smear).

Liver aspirate material is rarely examined, and often the specimen was not collected properly. Aspirated material must be aliquoted into several different containers as it is removed from the abscess; amebae may be found only in the last portion of the aspirated material, theoretically material from the abscess wall, not necrotic debris from the abscess center.

Antigen Detection.

A number of enzyme immunoassay reagents are commercially available, and their specificity and sensitivity provide excellent options for the clinical laboratory. These tests can differentiate the E. histolytica/E. dispar group from the rest of the Entamoeba species, such as nonpathogenic Entamoeba coli or Entamoeba hartmanni. Other test reagents can distinguish between E. histolytica and E. dispar (Entamoeba histolytica II test, TechLab, Blacksburg, VA or Entamoeba CELESA path, Cellabs, Brookvale, Australia). These kits require fresh or frozen stool; fecal preservatives have been found to interfere with the Entamoeba spp. reagents. Because of the specificity of the immunoassay reagents, the laboratory can inform the physician whether the E. histolytica/E. dispar organisms seen in the stool specimen are pathogenic E. histolytica or nonpathogenic E. dispar. Without the use of these reagents, the only way to identify true pathogenic E. histolytica morphologically is to detect the rare presence of trophozoites containing ingested RBCs. If the laboratory does not use these reagents, the presence of E. histolytica/E. dispar should be reported to the physician, accompanied by commentary related to the newer information on pathogenicity. Depending on each state’s requirements, pathogenic E. histolytica generally is reported to the public health facility (county).

Antibody Detection.

Serologic testing for intestinal disease is rarely recommended unless the patient has true dysentery; even in these cases, the titer (e.g., indirect hemagglutination) may be low and thus difficult to interpret. A definitive diagnosis of intestinal amebiasis should not be made without demonstrating the presence of the organisms. In patients suspected of having extraintestinal disease, serologic tests are diagnostically more effective. Indirect hemagglutination and indirect fluorescent antibody tests have been reported positive with titers greater than or equal to 1 : 256 and greater than or equal to 1 : 200, respectively, in almost 100% of cases of amebic liver abscess. In the absence of STAT serologic tests for amebiasis (tests with very short turnaround times for results), the decision on diagnosis must be made on clinical grounds and on the basis of results of other diagnostic tests, such as scans.

Therapy

Two classes of drugs are used in the treatment of amebic infections: luminal amebicides, such as iodoquinol or diloxanide furoate, and tissue amebicides, such as metronidazole, chloroquine, or dehydroemetine. Because of the differences in drug efficacy, it is important that the laboratory report indicates whether cysts, trophozoites, or both are present in the stool specimen.

Hepatic Disease.

Metronidazole plus one of the luminal drugs should be used to treat hepatic disease. Some other combinations also can be used; some contain emetine, in which case the patient must be monitored very carefully for possible cardiotoxicity. The importance of using both luminal and tissue amebicides is emphasized in patients with amebic liver abscesses. Asymptomatic colonization may be present with the true pathogen, E. histolytica. In patients treated with metronidazole (tissue amebicide), generally a 100% clinical response to the hepatic lesions is seen; however, failure to eliminate the organism from the bowel can lead to second bouts with invasive disease and intestinal colonization. Also, these carriers constitute a public health hazard because of continued shedding of infective cysts.

Prevention

Humans are the reservoir host for E. histolytica, and infection can be transmitted to other humans, primates, dogs, cats, and possibly pigs. Accidental consumption of sewage-contaminated water provides another route of infection. Amebiasis is considered a zoonotic waterborne infection. The cyst stages are resistant to environmental conditions and can remain viable in the soil for 8 days at 28° to 34°C, for 40 days at 2° to 6°C, and for 60 days at 0°C. Cysts normally are removed by sand filtration or destroyed by 200 ppm of iodine, 5% to 10% acetic acid, or boiling. However, an asymptomatic carrier who is a food handler generally is thought to play the most important role in transmission. Proper disposal of contaminated feces is considered the most important preventive measure. Although vaccines have been discussed as a possibility for eliminating human disease, nothing currently is available.

Entamoeba coli

General Characteristics

The life cycle of E. coli is identical to that of E. dispar. After digestion of infective cysts, the organisms excyst in the intestinal tract and produce trophozoites. Cyst formation occurs as the gut contents move through the intestinal tract; the excreted cysts are the infective form that is transmitted to humans and some animals.

E. coli trophozoites are somewhat larger than those of E. histolytica and E. dispar and range from 15 to 50 µm in diameter (see Table 48-1; Figures 48-6 and 48-7; see Figure 48-3). Motility is sluggish with broad, short pseudopods. In wet preparations, differentiating nonpathogenic E. coli from pathogenic E. histolytica is almost impossible. On the permanent stained smear viewed at a higher magnification, the cytoplasm is granular with vacuoles containing bacteria, yeasts, and other food materials. The nucleus has a large blotlike karyosome that may be eccentric rather than centrally located. The chromatin on the nuclear membrane tends to be clumped and irregular. Although rare, if RBCs are present in the intestinal tract, E. coli may ingest them rather than bacteria.

Early cysts often contain chromatoidal bars, which tend to be splinter shaped and irregular. Eventually, the nuclei divide until the mature cyst, containing eight nuclei, is formed (see Table 48-2; see Figures 48-3 and 48-6). In rare cases, the number of nuclei reaches 16. The cysts measure 10 to 35 µm in diameter, and as they mature, the chromatoidal bars disappear. When the cyst of E. coli matures, it becomes more refractive to fixation; therefore, the cyst may be seen on the wet preparation but not on the permanent stained smear. Occasionally, on trichrome smears, the cysts appear distorted and somewhat pink (Figure 48-8).

Entamoeba hartmanni

General Characteristics

The life cycle of E. hartmanni is similar to that of E. dispar, with differences in size (Figures 48-9 and 48-10). In wet preparations, E. hartmanni trophozoites range in size from 4 to 12 µm in diameter, and cysts range in size from 5 to 10 µm in diameter. On the permanent stained smear, the cysts, primarily, tend to shrink as a result of dehydration; therefore, the sizes of all the organisms, including pathogenic E. histolytica, may be somewhat smaller (1 to 1.5 µm) than the wet preparation measurements.

Trophozoites do not ingest RBCs, and the motility is usually less rapid (see Table 48-1; see Figures 48-3, 48-9, and 48-10). The morphologic characteristics of E. hartmanni are very similar to those of E. histolytica, with two exceptions. Frequently, E. hartmanni cysts may contain only one or two nuclei, even though the mature cyst contains four nuclei. Mature cysts of E. hartmanni also retain their chromatoidal bars, a characteristic not usually seen in E. histolytica/E. dispar. E. hartmanni’s chromatoidal bars are similar to those of E. histolytica and E. dispar but smaller and more numerous (see Table 48-2; see Figures 48-9 and 48-10). At the species level, differentiation between E. hartmanni and E. histolytica/E. dispar depends on size; therefore, laboratories are required to use calibrated microscopes that are checked periodically for accuracy.

Endolimax nana

General Characteristics

Endolimax nana, one of the smaller nonpathogenic amebae, has a worldwide distribution and is seen as frequently as E. coli.

E. nana has the same life cycle stages as E. dispar and the other nonpathogenic amebae. The trophozoite usually measures 6 to 12 µm in diameter (normal range, 8 to 10 µm) (see Table 48-1; Figures 48-11 to 48-13). Although rarely seen, motility is sluggish and nonprogressive with blunt, hyaline pseudopods. In the permanent stained smear, normally no peripheral chromatin is seen on the nuclear membrane, and the karyosome is large, with either a central or an eccentric location in the nucleus (see Figures 48-12 and 48-13). E. nana shows more nuclear variation than any of the other amebae, and occasionally E. nana can mimic D. fragilis or E. hartmanni. The cytoplasm may have small vacuoles containing ingested debris or bacteria, but it also may appear relatively clean.

Cysts usually measure 5 to 10 µm in diameter (normal range, 6 to 8 µm) (see Table 48-2). Cysts as large as 14 µm have been seen. The cyst is usually oval to round, with the mature cyst containing four nuclei. The nuclei typically have no peripheral chromatin and are somewhat evenly distributed in the cyst. Occasionally, very small, slightly curved chromatoidal bars are present. The two-nucleated stage is not commonly seen, and frequently both trophozoites and cysts are present in clinical specimens.

Iodamoeba bütschlii

General Characteristics

Iodamoeba bütschlii, one of the nonpathogenic amebae, has a worldwide distribution. Generally, the acquisition rate for this organism is not as high as that for E. coli and E. nana.

The life cycle stages of I. bütschlii are exactly the same as those of E. nana. The trophozoite varies from 8 to 20 µm in diameter and has fairly active motility in a fresh stool preparation (see Table 48-1). The cytoplasm is granular, containing numerous vacuoles with ingested debris and bacteria. The cytoplasm is more vacuolated than in E. nana trophozoites. The nucleus has a large karyosome, which can be either centrally located or eccentric (Figures 48-14 and 48-15). On the permanent stained smear, the nucleus may appear to have a halo, and chromatin granules fan out around the karyosome. If the granules are on one side, the nucleus may appear to have a “basket nucleus” arrangement of chromatin, more commonly seen in the cyst stage. The trophozoites of I. bütschlii and E. nana may appear similar and are difficult to differentiate at the species level, even on the permanent stained smear. Both organisms are considered nonpathogenic. E. nana is recovered in clinical specimens much more frequently than is I. bütschlii.

I. bütschlii cysts are round to oval (see Table 48-2). The glycogen vacuole is so large that occasionally the cyst collapses on itself. Because nuclear multiplication does not occur in the cyst form, the mature cyst contains a single nucleus. The cysts measure approximately 5 to 20 µm in diameter and are rarely confused with those of other amebae (see Figures 48-14 and 48-15).

Blastocystis hominis

General Characteristics

Blastocystis hominis (see Figure 48-1; see Table 48-6) comprises a number of different strains that are indistinguishable morphologically; some of which are pathogenic, and some are nonpathogenic. Although usually listed with the amebae, the organism’s classification is still under review; different strains eventually may be classified as different species. Although the true role of this organism in terms of disease has been controversial, it is now generally considered a causative agent of intestinal disease. The current recommendation is to report the presence of B. hominis and quantitate from the permanent stained smear (i.e., rare, few, moderate, many, packed); this information may be valuable in helping to assess the pathogenicity of the organism in the individual patient.

B. hominis consists of four major forms. The cyst form is the most recently described form of the life cycle stages. Thick-walled cysts are thought to be responsible for external transmission through the fecal-oral route; thin-walled cysts are thought to cause autoinfection. Cysts can vary in shape but are mostly ovoid or spherical. The central vacuole form (also referred to as the central body form) is the most common form found in clinical stool samples. The large central vacuole can occupy most of the cellular volume. The amoeboid form is rarely seen. The granular form can be seen in cultures of B. hominis.

Laboratory Diagnosis

Flagellates

The Mastigophora, or flagellates, have specialized locomotor organelles called flagella; these are long, thin, cytoplasmic extensions that may vary in number and position, depending on the species. Different genera of flagellates may live in the intestinal tract, the bloodstream, or various tissues.

Four common species of flagellates are found in the intestinal tract: Giardia lamblia, Dientamoeba fragilis, Chilomastix mesnili, and Pentatrichomonas hominis (Figures 48-16 to 48-23) (see Tables 48-3 and 48-4). Several other smaller, nonpathogenic flagellates, such as Enteromonas hominis and Retortamonas intestinalis (see Figure 48-16), are rarely seen, and none are identified in the intestinal tract. The sucking disk and axonemes of G. lamblia, the cytostome and spiral groove of C. mesnili, and the undulating membrane of Trichomonas spp. are all distinctive criteria for identification (see Figures 48-16 to 48-23).

G. lamblia and D. fragilis are the flagellates considered pathogenic. D. fragilis has been associated with diarrhea, nausea, vomiting, and other nonspecific intestinal complaints. Trichomonas vaginalis is pathogenic but occurs in the urogenital tract. Trichomonas tenax is occasionally found in the mouth and may be associated with poor oral hygiene.

Giardia lamblia

General Characteristics

G. lamblia is the most common cause of intestinal infection worldwide. Other than B. hominis, G. lamblia (also called G. duodenalis and G. intestinalis) is probably the most common protozoan organism identified in individuals in the United States. It causes symptoms ranging from mild diarrhea, flatulence, and vague abdominal pains to acute, severe diarrhea to steatorrhea and a typical malabsorption syndrome. Various documented waterborne and food-borne outbreaks have occurred during the past several years. A number of animals may serve as reservoir hosts for G. lamblia. Differentiation of flagellates is based on overall shape, numbers, and arrangements of flagella.

Both the trophozoite and cyst stages are included in the life cycle of G. lamblia. Trophozoites divide by means of longitudinal binary fission, producing two daughter trophozoites. The organism is found most commonly in the crypts in the duodenum. Trophozoites are the intestinal dwelling stage and attach to the epithelium of the host villi by means of the ventral disk. The attachment is substantial and results in disk “impression prints” when the organism detaches from the surface of the epithelium. Trophozoites may remain attached to or may detach from the mucosal surface. Because the epithelial surface sloughs off the tip of the villus every 72 hours, the trophozoites apparently detach at that time. G. lamblia trophozoites are teardrop shaped and have been described as “someone looking at you” (see Figures 48-16 to 48-18).

Cyst formation takes place as the organisms move down through the jejunum after exposure to biliary secretions. The trophozoites retract the flagella into the axonemes, the cytoplasm becomes condensed, and the cyst wall is secreted (see Figures 48-16 to 48-18). As the cyst matures, the internal structures are doubled, so that when excystation occurs, the cytoplasm divides, producing two trophozoites. Excystation occurs in the duodenum or appropriate culture medium.

Epidemiology

Transmission of G. lamblia occurs by ingestion of viable cysts. Although contaminated food or drink may be the source, intimate contact with an infected individual may also result in transmission of the organism. This organism is found more frequently in children or in groups living in close quarters. Outbreaks have been associated with poor sanitation facilities or sanitation breakdowns, as evidenced by infections of travelers and campers. Limited information is available on seasonal variations in giardiasis. Some data suggest an association with the cooler, wetter months of the year, which may implicate environmental conditions as advantageous to cyst survival. Certain occupations may place an individual at risk for infection, such as sewage and irrigation workers, who may be exposed to infective cysts. In situations in which young children are grouped together, such as in nursery schools, an increased incidence of exposure and subsequent infection of both children and staff members may be seen. A high incidence of giardiasis occurs in patients with immunodeficiency syndromes, particularly in those with common variable hypogammaglobulinemia. Giardiasis is the most common cause of diarrhea in these patients and may be associated with mild to severe villus atrophy.

An estimated 200 million people in Asia, Africa, and Latin America have symptomatic infections. In the United States, approximately 20,000 cases are reported yearly. However, an estimated 2 million cases may occur annually.

Pathogenesis and Spectrum of Disease

The incubation period for giardiasis ranges from approximately 12 to 20 days. Giardiasis may not be recognized as the cause, because the infection mimics acute viral enteritis, bacillary dysentery, bacterial or other food poisonings, acute intestinal amebiasis, or “traveler’s diarrhea” (toxigenic Escherichia coli). However, the type of diarrhea plus the lack of blood, mucus, and cellular exudate is consistent with giardiasis.

Intestinal Disease.

For unknown reasons, symptomatic patients may have irritation of the mucosal lining, increased mucus secretion, and dehydration. The onset may be accompanied by nausea, anorexia, malaise, low-grade fever, and chills, in addition to a sudden onset of explosive, watery, foul-smelling diarrhea. Other symptoms include epigastric pain, flatulence, and diarrhea with increased amounts of fat and mucus in the stool but no blood. Weight loss often accompanies these symptoms. Although some speculate that the organisms coating the mucosal lining may act to prevent fat absorption, this does not completely explain the prevention of the uptake of other substances normally absorbed at other intestinal levels. Severe malabsorption has also been linked with isolated levothyroxine malabsorption, leading to severe hypothyroidism and secondary impairment of pancreatic function. In both cases, treatment with metronidazole led to complete remission of symptoms. Occasionally the gallbladder is involved, resulting in gallbladder colic and jaundice. G. lamblia also has been identified in bronchoalveolar lavage fluid.

Chronic Disease.

The acute phase often is followed by a subacute or chronic phase. Symptoms include recurrent, brief episodes of loose, foul-smelling stools and possibly increased distention and foul flatus. Between episodes of mushy stools, the patient may have normal stools or may be constipated. Abdominal discomfort includes marked distention and belching with a rotten-egg taste. Chronic disease must be differentiated from amebiasis; disease caused by other intestinal parasites (e.g., D. fragilis, Cryptosporidium spp., Cyclospora cayetanensis, Isospora belli, Strongyloides stercoralis); inflammatory bowel disease; and irritable colon. On the basis of symptoms such as upper intestinal discomfort, heartburn, and belching, giardiasis must also be differentiated from duodenal ulcer, hiatal hernia, and gallbladder and pancreatic disease.

Laboratory Diagnosis

Routine Methods.

Routine stool examinations are normally recommended for the recovery and identification of intestinal protozoa. However, in the case of G. lamblia, because the organisms are attached securely to the mucosa by means of the sucking disk, a series of five or six stool samples may be examined without recovering the organism. The organisms also tend to be passed in the stool on a cyclic basis. The Entero-Test capsule can be helpful for recovering the organisms, as can the duodenal aspirate. Although cysts often can be identified on the wet stool preparation, many infections may be missed without examination of a permanent stained smear. If material from the string test (Entero-Test, HDC Corp., San Jose, CA) or mucus from a duodenal aspirate is submitted, it should be examined as a wet preparation for motility; however, motility may be represented by nothing more than a slight flutter of the flagella, because the organism is caught up in the mucus. After diagnosis, the positive specimen can be preserved as a permanent stain.

Antigen Detection.

The development of fecal immunoassays to detect Giardia antigen in stool has dramatically improved the sensitivity seen with the routine O&P examination. The ELISA has been used to detect Giardia antigen in feces. Fluorescent methods with monoclonal antibodies have also proven extremely sensitive and specific in detecting G. lamblia in fecal specimens. Other products are available as a cartridge format that uses an immunochromatographic strip–based detection system for G. lamblia and/or Cryptosporidium spp. Any antigen detection system should always be reviewed for compatibility with stools submitted in preservatives rather than fresh specimens. Some limitations exist on the use of kits for organisms in the genus Entamoeba. However, commercial reagent kits for detecting Giardia and Cryptosporidium spp. can be used with formalin-based stool preservatives or with fresh or frozen specimens. Many of these cartridge format tests provide an answer within 10 minutes and are equal to or better than other immunoassays with regard to sensitivity and specificity. Many of these newer methods are being used to test patients suspected of having giardiasis or those who may be involved in an outbreak.

The detection of antigen in stool or visual identification of organisms by using monoclonal antibody reagents indicates current infection. The value of these detection assays as rapid, reliable immunodiagnostic procedures has been emphasized by the increase in Giardia infections and the greater awareness of particular incidences (e.g., nursery school settings). Because the organisms are shed so sporadically, use of a fecal immunoassay does not eliminate the need to analyze multiple stool specimens for sensitive detection of G. lamblia; a minimum of two stools should be tested. If the first specimen is negative, it may represent a false negative.

Histology.

Trophozoites are detectable in the duodenum and proximal jejunum; however, mucosal invasion generally has been found in areas where necrosis or mechanical trauma was present. Changes range from normal to almost complete villus atrophy, with a greater density of inflammatory infiltrate in the lamina propria when villus atrophy is present. The amount of villus damage seems to correlate with the degree of malabsorption. Apparently, patients with giardiasis also have reduced mucosal surface areas compared with control patients.

Histologic changes in the mucosal architecture in immunodeficient patients with giardiasis also range from mild to severe villus atrophy. It appears that giardiasis produces a more severe degree of villus damage in patients with hypogammaglobulinemia. In patients with acquired immunodeficiency syndrome (AIDS), giardiasis does not appear to be an important pathogen, although the infection has certainly been found in this group and in homosexual men.

Prevention

The most effective practice for preventing the spread of infection in the child care setting is thorough hand washing by the children, staff members, and visitors. Rubbing the hands together under running water is the most important part of washing away infectious organisms. Premoistened towelettes or wipes and waterless hand cleaners should not be used as substitutes for washing the hands with soap and running water. These guidelines are not limited to giardiasis but include all potentially infectious organisms.

Because wild animals and possibly domestic animals serve as reservoir hosts, personal hygiene, improved sanitary measures, and safe drinking water are considerations. Iodine has been recommended as an effective disinfectant for drinking water. Filtration systems have also been recommended, although they have certain drawbacks, such as clogging.

Chilomastix mesnili

General Characteristics

C. mesnili has both trophozoite and cyst stages and is somewhat more easily identified than are some of the smaller flagellates, such as E. hominis and R. intestinalis (see Tables 48-3 and 48-4; see Figure 48-19). The C. mesnili trophozoite is pear shaped, measuring 6 to 24 µm long and 4 to 8 µm wide. It has a single nucleus and a distinct oral groove, or cytostome (mouth), close to the nucleus. Flagella are difficult to see without obvious motility in a wet preparation. The morphology can be seen on the permanent stained smear; the cytostome may be visible in some trophozoites. The cysts are pear or lemon shaped and range from 6 to 10 µm long and 4 to 6 µm wide (see Figure 48-20). They have a single nucleus and a typical curved cytostomal fibril, called the shepherd’s crook. The cyst’s definitive morphology can be seen on a permanent stain.

Dientamoeba fragilis

General Characteristics

D. fragilis was described in 1918. It has a worldwide distribution, and surveys report incidence rates of 1.4% to 19%. Much higher incidence figures have been reported for patients in mental institutions, missionaries, and Native Americans in Arizona. D. fragilis tends to be common in some pediatric populations, and the incidence is higher for patients under 20 years of age in some studies. Some speculate that D. fragilis may be infrequently recovered and identified; a low incidence or absence from survey studies may be due to poor laboratory techniques and a general lack of knowledge about the organism.

The D. fragilis trophozoite is characterized as having one nucleus (20% to 40%) or two nuclei (60% to 80%). The nuclear chromatin usually is fragmented into three to five granules, and normally no peripheral chromatin is seen on the nuclear membrane. In some organisms the nuclear chromatin tends to mimic that of E. nana, E. hartmanni, or even C. mesnili, particularly if the organisms are overstained with trichrome or iron-hematoxylin stain. The cytoplasm is usually vacuolated and may contain ingested debris and some large, uniform granules. The cytoplasm can also appear uniform and clean with few inclusions. Size and shape vary considerably among organisms, even on a single smear.

Laboratory Diagnosis

Routine Methods.

Diagnosis of D. fragilis infections depends on proper collection and processing techniques (a minimum of three fecal specimens). Although the survival time for this parasite has been reported as 24 to 48 hours in the trophozoite form, the survival time in terms of morphology is limited, and stool specimens must be examined immediately or preserved in a suitable fixative soon after defecation. It is particularly important to examine permanent stained smears of stool with an oil immersion objective (×100).These trophozoites have been recovered in formed stool; therefore, a permanent stained smear must be prepared for every stool sample submitted for examination. Organisms seen in direct wet mounts may appear as refractile, round forms; the nuclear structure cannot be seen without examination of the permanent stained smear.

Pentatrichomonas hominis

P. hominis is probably the most commonly identified flagellate, other than G. lamblia and D. fragilis. P. hominis has been recovered from all parts of the world, in both warm and temperate climates, and is considered nonpathogenic and noninvasive. It is not known to have a cyst stage (see Figure 48-16). P. hominis trophozoites live in the cecum and feed on bacteria. The trophozoite measures 5 to 15 µm long and 7 to 10 µm wide. It has a pyriform shape and has both an axostyle and an undulating membrane, which aid identification of the organism. The undulating membrane extends the entire length of the body, in contrast to that seen in the pathogen T. vaginalis (on which the membrane extends halfway down the body).

Ciliates

The class Ciliata, or ciliates, includes species that move by means of cilia, or short extensions of cytoplasm that cover the surface of the organism. The ciliates also have two different types of nuclei, one macronucleus and one or more micronuclei. This group includes only one organism that infects humans, Balantidium coli, which infects the intestinal tract and may produce severe symptoms.

Balantidium coli

General Characteristics

The life cycle of B. coli includes both the trophozoite and cyst stages (Figures 48-24 and 48-25). The cyst form is the infective stage. After ingestion of the cysts and excystation, trophozoites secrete hyaluronidase, which aids the invasion of the colonic tissue.

The trophozoite is quite large, oval, and covered with short cilia. It measures approximately 50 to 150 µm long and 40 to 70 µm wide. The organism can be seen in a wet preparation on lower power. The anterior end is somewhat pointed and has a cytostome (primitive mouth opening); in contrast, the posterior end is broadly rounded. The cytoplasm contains many vacuoles with ingested bacteria and debris. The trophozoite has two nuclei: one very large, bean-shaped macronucleus and a smaller, round micronucleus. The organisms live in the large intestine. The trophozoites have a rapid, rotatory, boring motion because of the movement of the cilia. The cyst is formed as the trophozoite moves down the intestine. Nuclear division does not occur in the cyst; therefore, only two nuclei are present, the macronucleus and the micronucleus. The cysts measure 50 to 70 µm in diameter (see Table 48-5).

Pathogenesis and Spectrum of Disease

Some individuals with B. coli infection are asymptomatic, whereas others have severe dysentery, similar to that seen in patients with amebiasis. Symptoms include diarrhea or dysentery, tenesmus, nausea, vomiting, anorexia, and headache. Insomnia, muscular weakness, and weight loss also have been reported. Diarrhea may persist for weeks to months, with or without subsequent development of dysentery. Tremendous fluid loss may occur, with diarrhea similar to that seen in cholera or in some coccidial or microsporidial infections.

B. coli can invade tissue. It may penetrate the mucosa on contact, with cellular infiltration in the area of the developing ulcer. Some of the abscess formations may extend to the muscular layer. The ulcers may vary in shape, and the ulcer bed may be full of pus and necrotic debris. Although the number of cases is small, extraintestinal disease (peritonitis, urinary tract infection, inflammatory vaginitis) has been reported.

Sporozoa (Apicomplexa)

All the Apicomplexa are unicellular and have an apical complex. These structures can be seen in electron microscopy studies and are used to help classify the various organisms. Genera that develop in the gastrointestinal tract of vertebrates throughout their entire life cycle include Isospora, Cyclospora, and Cryptosporidium. Genera capable of or requiring extraintestinal development are referred to as cyst-forming coccidia; they include Sarcocystis and Toxoplasma spp. The genera that cause disease in humans include Cryptosporidium, Cyclospora, Isospora, Sarcocystis, and Toxoplasma (see Chapter 50 for a discussion of Toxoplasma).

Cryptosporidium spp.

General Characteristics

Cryptosporidium spp. are intracellular parasites that primarily infect epithelial cells of the stomach, intestine, and biliary ducts. The organism previously called Cryptosporidium parvum, thought to be the primary Cryptosporidium species infecting humans, now is classified as two species, C. parvum (mammals, including humans) and C. hominis (primarily humans) (see Table 48-6, Figures 48-26 to 48-28). Differentiation of these two species based on oocyst morphology is not possible. Currently, more than 20 established Cryptosporidium species have been identified in vertebrates, and more than 10 Cryptosporidium spp. have been reported in humans.

Cryptosporidium infections begin with ingestion of viable oocysts. Upon contact with gastric and duodenal fluid, each oocyst releases four sporozoites, which invade the epithelial cells and develop into trophozoites surrounded by a parasitophorous vacuole (layers of endoplasmic reticulum around an intracellular parasite). In the epithelial cells, trophozoites undergo two or three generations of asexual amplification, called merogony, leading to the formation of different types of meronts containing four to eight merozoites. The merozoites differentiate into sexually distinct stages in a process called gametogony. New oocysts are then formed in the epithelial cells in a process called sporogony. About 20% of the oocysts are thin walled and may excyst in the digestive tract of the host, leading to the infection of new cells (autoinfection). The remaining 80% of the oocysts are excreted into the environment; are resistant to low temperature, high salinity, and most disinfectants; and can initiate infection in a new host. Cryptosporidium oocysts in humans measure 4 to 6 µm in diameter.

Epidemiology

Humans can acquire cryptosporidiosis through several transmission routes, such as direct contact with infected people or animals or consumption of contaminated water (drinking or recreational) or food. The interval between ingestion of infective oocysts to completion of the life cycle and excretion of new oocysts usually is 4 to 10 days. The only extracellular stage in the Cryptosporidium life cycle is the oocysts; these are the environmental stage of the parasite and are immediately infectious when passed in the stool.

Cryptosporidium spp. have a worldwide distribution, and the oocysts are ubiquitous in the environment. In developing countries, human Cryptosporidium infection occurs mostly in children younger than 5 years, with peak occurrence of infections and diarrhea in children under 2 years of age. In developed countries, pediatric cryptosporidiosis occurs in older children, probably because, as a result of better hygiene, exposure to contaminated environments occurs later. Cryptosporidiosis is also common in the elderly in nursing homes, where person-to-person transmission occurs. In the general population, sporadic infections occur in all age groups in the United States and the United Kingdom, and traveling to developing countries and consumption of contaminated food and water can lead to infection. Cryptosporidiosis is common in immunocompromised individuals, such as those with AIDS or primary immunodeficiency and cancer and transplant patients undergoing immunosuppressive therapy.

Calves and perhaps other animals serve as potential sources of human infection. Contact with these animals may be an unrecognized cause of gastroenteritis in humans in both rural and urban settings. Direct person-to-person transmission is also likely and may occur through direct or indirect contact with stool material. Direct transmission may occur during sexual practices involving oral-anal contact. Indirect transmission may occur through exposure to positive specimens in a laboratory setting or from contaminated surfaces or food or water.

Pathogenesis and Spectrum of Disease

Immunocompetent Individuals.

In immunocompetent people with sporadic cryptosporidiosis in industrialized nations, the most common symptom is diarrhea. Clinical symptoms include nausea, low-grade fever, abdominal cramps, anorexia, and five to 10 watery, frothy bowel movements per day, which may be followed by constipation. Some patients may have diarrhea, and others may have few symptoms, particularly later in the course of the infection. In patients with the typical watery diarrhea, the stool contains mainly water and mucus. Often the organisms are entrapped in the mucus, and diagnostic procedures are performed accordingly. Generally a patient with a normal immune system has a self-limited infection; however, patients who are immunocompromised may have a chronic infection with a wide range of symptoms. The illness usually lasts 9 to 21 days and may require hospitalization in up to 20% of those infected. Patients infected with C. hominis are more likely to have joint pain, eye pain, recurrent headache, dizziness, and fatigue than those infected with C. parvum.

Immunocompromised Individuals.

Hemodialysis patients with chronic renal failure and renal transplant patients with cryptosporidiosis can have chronic, life-threatening diarrhea. In individuals infected with the human immunodeficiency virus (HIV), cryptosporidiosis increases as the CD4+ lymphocyte count falls, especially below 200 cells/µL. Sclerosing cholangitis and other biliary involvement are also seen in AIDS patients with cryptosporidiosis. The combination of AIDS and cryptosporidiosis often leads to increased mortality and diminished survival. In these patients, Cryptosporidium infections are not always confined to the gastrointestinal tract; additional symptoms (respiratory problems, cholecystitis, hepatitis, and pancreatitis) have been associated with extraintestinal infections. Although the clinical features of sclerosing cholangitis secondary to opportunistic infections of the biliary tree in patients with AIDS are well known, the mechanisms by which pathogens such as Cryptosporidium spp. actually cause disease are unclear.

Laboratory Diagnosis

Antigen Detection.

Immunoassays are very helpful, because they are a more sensitive method of detecting organisms in stool specimens. A direct fluorescent antigen (FA) procedure with excellent specificity and sensitivity has been developed and results in a significantly increased detection rate over conventional staining and microscopy methods. Some of these reagents, particularly the combination direct FA product used to identify both Giardia spp. cysts and Cryptosporidium spp. oocysts, are being widely used in water testing and outbreak situations. Most antibodies in commercial direct fluorescent antibody (DFA) kits react with oocysts of almost all Cryptosporidium species, making identification to the species level impossible. Enzyme immunoassay (EIA) tests also provide excellent specificity and sensitivity for laboratories using this approach, as do the immunochromatographic cartridge rapid test formats. It is important to remember that if a patient is in the carrier state or undergoing self-cure, the number of oocysts may drop below the sensitivity levels of these kits, producing a false-negative result.

Histology.

In the examination of histologic preparations, developmental stages (sporozoites, trophozoites, merozoites, and oocysts) in the life cycle of Cryptosporidium spp. can be found at all levels of the intestinal tract, with the jejunum being the most heavily infected site. Routine hematoxylin and eosin staining is sufficient to demonstrate these parasites. Under regular light microscopy, the organisms are visible as small, round structures (about 1 to 3 µm in diameter) aligned along the brush border. They are intracellular but extracytoplasmic and are found in parasitophorous vacuoles. Developmental stages are more difficult to identify without a transmission electron microscope. It also is important to remember that in severely compromised patients, Cryptosporidium spp. have been found in other body sites, primarily the lungs, as a disseminated infection.

Therapy

Oral or intravenous rehydration and antimotility drugs are used whenever severe diarrhea is associated with cryptosporidiosis. Nitazoxanide is the only drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptosporidiosis in immunocompetent individuals. This drug can shorten the clinical disease and reduce the number of parasites present. However, nitazoxanide is not effective in treating cryptosporidiosis in immunodeficient patients; paromomycin and spiramycin have been used in these individuals.

In industrialized nations, the most effective prophylaxis and treatment for cryptosporidiosis in patients with AIDS is highly active antiretroviral therapy (HAART). Eradication and prevention of the infection are related to replenishment of CD4+ cells in treated individuals and the antiparasitic activities of the protease inhibitors used in HAART. Relapse of cryptosporidiosis is common in patients with AIDS who have stopped HAART.

Cyclospora cayetanensis

General Characteristics

During the past few years, a number of outbreaks of diarrhea associated with Cyclospora cayetanensis have occurred; the distribution is worldwide (United States, Caribbean, Central and South America, Southeast Asia, Eastern Europe, Australia, Nepal). These organisms are acid-fast variable and have been found in the feces of immunocompetent travelers to developing countries, immunocompetent individuals with no travel history, and patients with AIDS. Cumulative evidence suggests that outbreaks in the United States and Canada during the spring months of 1996 and 1997 were related to the importation and ingestion of Guatemalan raspberries. An outbreak in Florida in 1995 quite likely was also attributable to contaminated food. The cases reported in all three outbreaks probably represented only a small fraction of incidences.

The life cycle of C. cayetanensis involves only humans as hosts. Oocysts are passed in the feces unsporulated (Figure 48-29). At room temperature (23° to 25°C), small numbers of oocysts may sporulate within 10 to 12 days.

In clean wet mounts, Cyclospora organisms are seen as nonrefractile spheres, which are difficult to recognize as parasites. Unless a high number of oocysts are present, they may easily be mistaken for artifacts. They are acid-fast variable with the modified acid-fast stain; those that are unstained appear as glassy, wrinkled spheres (wrinkled cellophane). The oocysts are twice the size of those of Cryptosporidium spp. and measure 8 to 10 µm in diameter. Because it takes 10 days to 2 weeks for the oocysts to sporulate, no internal structures are visible (sporozoites), as can be seen in Cryptosporidium organisms.

Epidemiology

Transmission of C. cayetanensis is thought to be by the fecal-oral route. However, direct person-to-person transmission has not been well documented and may not be a factor, because sporulation takes a number of days. Outbreaks linked to contaminated water and various types of fresh produce (raspberries, basil, baby lettuce leaves, and snow peas) have been reported. Information on reservoir hosts is not well defined; however, in some areas humans appear to be the only host.

C. cayetanensis is endemic in Central and South America, the Caribbean, Mexico, Indonesia, Asia, Nepal, Africa, India, Southern Europe, and the Middle East. In endemic areas, contact with soil and water increases the risk of Cyclospora infection. Infections in most temperate areas are correlated with the consumption of imported contaminated fruits and vegetables,

Pathogenesis and Spectrum of Disease

Although some patients are asymptomatic, others report a flulike illness, marked by nausea, vomiting, anorexia, weight loss, and explosive diarrhea lasting 1 to 3 weeks. The incubation period is not yet known. However, the onset of symptoms after infection generally averages 7 to 8 days, and the symptoms last 2 to 3 weeks. Oocyst shedding in the feces is highly variable and may range from 7 days to several months. Indigenous infections are confined primarily to tropical, subtropical, or warm temperate regions of the world. Outbreaks occur in other areas of the world as a result of contaminated foodstuffs.

In immunocompromised and immunocompetent patients, C. cayetanensis infection can be associated with biliary disease. With light and transmission electron microscopy, developmental stages have been seen in the gallbladder epithelium of AIDS patients with acalculous cholecystitis. Also, oocysts have been seen in the bile of patients with active biliary disease.

Laboratory Diagnosis

C. cayetanensis oocysts do not routinely stain with the trichrome fecal stain; special methods are required for identification. The oocysts can be concentrated using routine methods; special stains can then be used to enhance morphology. A single negative stool specimen is not conclusive in the examination of stools for coccidia; a total of three stool specimens collected on subsequent days must be examined before infection can be ruled out.

Special Stains.

With modified acid-fast stains, the oocysts appear light pink to deep red, and some contain granules or have a bubbly appearance (described as wrinkled cellophane). It is very important to be aware of these organisms when the modified acid-fast stain is used, because Cryptosporidium spp. and other similar but larger structures (approximately twice the size of Cryptosporidium oocysts [8 to 10 µm]) are seen in the stained smear. Laboratories need to measure all acid-fast oocysts, particularly if they appear to be somewhat larger than those of Cryptosporidium spp. Variations on the safranin staining technique stain C. cayetanensis oocysts orange or pinkish orange, and heating and other treatments have been used to increase the staining frequency of oocysts. The oocysts autofluoresce green (450 to 490 DM excitation filter) or blue (365 DM excitation filter) under ultraviolet (UV) epifluorescence. It is strongly recommended that during concentration (formalin ethyl acetate) of stool specimens, centrifugation be carried out for 10 minutes at 500× g. The concentration sediment can then be stained, enhancing the sensitivity of the microscopy examinations.

Isospora (cystoisospora) belli

General Characteristics

Although isosporiasis is found worldwide, certain tropical areas in the Western Hemisphere have specific locations where endemic infections occur. These organisms infect both adults and children, and intestinal involvement and symptoms are generally transient unless the patient is immunocompromised. I. belli has also been implicated in traveler’s diarrhea. However, unlike with Cryptosporidium spp. and C. cayetanensis, large outbreaks of isosporiasis have not been reported (see Table 48-6, Figure 48-30).

I. belli oocysts are passed in the stool. They are long and oval, measuring 20 to 33 µm long by 10 to 19 µm wide. Usually the oocyst contains one immature sporont, but two may be present. Continued development occurs outside the body, with the development of two mature sporocysts, each containing four sporozoites, which can be recovered from the fecal specimen. The sporulated oocyst is the infective stage that excysts in the small intestine, releasing the sporozoites, which penetrate the mucosal cells and initiate the life cycle.

Epidemiology

I. belli oocysts are passed in the feces unsporulated or partially sporulated. Oocysts complete sporulation within 72 hours, although it may take longer, depending on the temperature. The time required for unsporulated oocysts to appear in the feces after ingestion of sporulated oocysts is 9 to 17 days. Oocyst shedding is variable and depends on the immune status of the infected individual. Oocysts can be found for 30 to 50 days in immunocompetent patients, and immunosuppressed patients may continue to shed oocysts for 6 months or longer. Chronic infections can occur, and oocysts can be shed for months to years. In one particular case, an immunocompetent individual had symptoms for 26 years, and I. belli was recovered in stool a number of times over 10 years.

I. belli is thought to be the only species of Isospora that infects humans, and no other reservoir hosts are recognized for this infection. Transmission occurs through ingestion of water or food contaminated with mature, sporulated oocysts. Sexual transmission by direct oral contact with the anus or perineum also occurs, although this mode of transmission is probably much less common. The oocysts are very resistant to environmental conditions and may remain viable for months if kept cool and moist; oocysts usually mature within 48 hours after stool passage and are then infectious.

Pathogenesis and Spectrum of Disease

Symptoms include diarrhea (most common), weight loss, abdominal colic, and fever. Stools (usually six to 10 per day) are watery to soft, foamy, and offensive smelling, suggesting a malabsorption process. Many patients have eosinophilia, recurrences are quite common, and the disease is more severe in infants and young children.

Patients who are immunosuppressed, particularly those with AIDS, often present with profuse diarrhea associated with weakness, anorexia, and weight loss. Biopsies reveal an abnormal mucosa with short villi, hypertrophied crypts, and infiltration of the lamina propria with eosinophils, neutrophils, and round cells. Physicians should consider I. belli in AIDS patients with diarrhea who have immigrated from or traveled to Latin America, are Hispanics born in the United States, are young adults, or who have not received prophylaxis with TMP-SMX for Pneumocystis infection. It has also been recommended that patients with AIDS traveling to Latin America and other developing countries be advised of the waterborne and food-borne transmission of I. belli and that chemoprophylaxis should be considered.

Extraintestinal infections in patients with AIDS have been reported. At autopsy, microscopic findings associated with I. belli infection were seen in the lymph nodes and walls of the small and large intestines, mesenteric and mediastinal lymph nodes, lymphatic channels, liver, and spleen. I. belli infections in the gallbladder epithelium and endometrial epithelium have also been reported, and oocysts have been recovered in bile specimens.

Laboratory Diagnosis

Examination of fresh material, either as the direct smear or as concentrated material, is recommended rather than the permanent stained smear. The oocysts are very pale and transparent and can easily be overlooked. The light level should be reduced, and additional contrast should be obtained with the microscope for optimal examination conditions. On the permanent stained smear, the organisms may take up excess stain and resemble helminth eggs or artifacts.

It is possible to have a positive biopsy specimen but not recover the oocysts in the stool because of the small numbers of organisms present. The oocysts are acid-fast and can also be demonstrated by using auramine rhodamine stains. Organisms tentatively identified by using auramine rhodamine stains should be confirmed by wet smear examination or acid-fast stains, particularly if the stool contains other cells or excess artifact material (more normal stool consistency). Currently, there are no commercially available nucleic acid-based methods for the detection of I. belli. However, PCR assays have been developed for the detection of the organism in stool samples.

Sarcocystis spp.

General Characteristics

Two well-described Sarcocystis species include S. bovihominis (cattle) and S. suihominis (pigs). (Some publications refer to S. bovihominis as S. hominis.) When uncooked meat from these infected animals is ingested by humans, gamogony (fission resulting in the production of sporozoan gametes) can occur in the intestinal cells, with eventual production of the sporocysts in stool.

Sarcocystis spp. have an obligatory two-host life cycle. Intermediate hosts (herbivores and omnivores) become infected through ingestion of sporocysts excreted in the feces of the definitive hosts (carnivores and omnivores). The definitive hosts become infected through ingestion of mature cysts found in the muscles of the intermediate hosts. In some intermediate hosts, such as cattle and sheep, all adult animals may be infected. Extraintestinal human sarcocystosis is rare, with a much lower incidence than is seen with the intestinal infection. Humans who have ingested meat containing the mature sarcocysts serve as the definitive hosts. Fever, severe diarrhea, abdominal pain, and weight loss have been reported in immunocompromised hosts, although the number of patients with these symptoms has been quite small.

The sporocysts found in the stool are broadly oval and slightly tapered at the ends. They measure 9 to 16 µm long and contain four mature sporozoites and the residual body (see Table 48-6). Normally, the oocyst contains two sporocysts (similar to I. belli); however, in Sarcocystis infections, the sporocysts are released from the oocyst and normally are seen singly. These sporocysts tend to be larger than Cryptosporidium oocysts that contain four sporozoites, so they look totally different. The oocysts are fully sporulated when passed in the stool.

Pathogenesis and Spectrum of Disease

When humans (intermediate host) ingest oocysts from other animal stool sources, the sarcocysts that develop in human muscle are 7 to 16 µm long and cause few, if any, problems. Basically, no inflammatory response to these organisms occurs in the muscle, and no evidence of pathogenicity is seen. Patients demonstrate symptoms related to the disintegration of the sarcocysts and death of intracystic bradyzoites. Painful muscle swellings measuring 1 to 3 cm in diameter are associated with erythema of the overlying skin; these occur periodically and last 2 days to 2 weeks. Symptoms also include fever, diffuse myalgia, muscle tenderness, weakness, eosinophilia, and bronchospasm. Different types of skeletal and cardiac muscle sarcocysts have been found in humans. No specific therapy is required for this type of infection. Corticosteroids can reduce allergic inflammatory reactions.

Infections in humans can manifest primarily as intestinal disease if infected meat is ingested or as muscular disease if sporocysts are ingested. Intestinal disease occurs within a few hours after consumption of infected meat and is characterized by nausea, abdominal pain, and diarrhea. However, in both situations patients may be infected and asymptomatic.

Laboratory Diagnosis

A presumptive diagnosis of intestinal disease may be based on the patient’s symptoms, particularly with documented ingestion of raw or poorly cooked meat. Confirmation of the diagnosis may depend on finding human fecal specimens containing sporocysts, which are passed in the stool 11 to 18 days after ingestion of beef or pork. Sporocysts of the two Sarcocystis species are very difficult to differentiate.

A muscle biopsy is appropriate for suspected symptomatic intramuscular infection in a patient with a history of travel to or residence in a tropical location. Sarcocysts in biopsy specimens can be identified by microscopy on routine histologic sections stained with hematoxylin and eosin. Most sarcocysts in humans have been found in skeletal and cardiac muscle; however, muscles in the larynx, pharynx, and upper esophagus have also been involved. No molecular assays are currently available for the detection of sarcocystis in humans. However, several amplification methods have been used to detect sarcocystis in intermediate hosts.

Microsporidia

Microsporidia are obligate intracellular, spore-forming parasites. More than 140 microsporidial genera and 1200 species have been identified. To date, seven genera (Anncaliia, Encephalitozoon, Enterocytozoon, Nosema, Pleistophora, Vittaforma, and Trachipleistophora) and unclassified microsporidia (Microsporidium) have been identified as causing human infections.

Although the microsporidia are true eukaryotes, they also have molecular and cytologic characteristics of prokaryotes. Microsporidia evolved from the fungi and are most closely related to the Zygomycetes. Features shared with fungi include the presence of chitin and trehalose, similarities in cell cycles, and certain gene organizations. Microsporidia are now considered highly derived fungi that underwent genetic and functional losses, resulting in one of the smallest eukaryotic genomes known. However, the life cycle of microsporidia is unique and unlike that of any fungal species. At this point, clinical and diagnostic issues and responsibilities may remain with the parasitologists, and we may be in a transition stage, similar to that seen with Pneumocystis jirovecii as it was moved from the parasites to fungi in terms of classification status.

General Characteristics

Human microsporidial infections have been documented worldwide. The spore, the only life cycle stage able to survive outside the host cell, is the infective stage (see Table 48-7 and Figures 48-31 to 48-35). Infection occurs with ingestion or inhalation of the infective spores, from which the infective sporoplasm (spore protoplasm) enters the host cell through the polar tubule. The microsporidia multiply extensively in the host cell cytoplasm; the life cycle includes repeated divisions by binary fission (merogony) or multiple fission (schizogony) and spore production (sporogony). Both merogony and sporogony can occur in the same cell at the same time. During sporogony, a thick spore wall is formed, providing environmental protection for the spore.

Microsporidial spores measure 0.7 to about 4 µm in diameter. Mature spores contain a tubular extrusion apparatus (polar tube or tubule) for injecting infective spore contents (sporoplasm) into the host cell.

Epidemiology

Transmission possibilities include human-to-human and animal-to-human routes. Many questions relating to reservoir hosts and possible congenital infections are still unanswered. Primary infection occurs through inhalation or ingestion of spores from environmental sources or by zoonotic transmission. The presence of Encephalitozoon intestinalis has been confirmed in tertiary sewage effluent, surface water, and groundwater; Enterocytozoon bieneusi has been confirmed in surface water; and Vittaforma corneae has been confirmed in tertiary effluent. This study represents the first confirmation, to the species level, of human-pathogenic microsporidia in water, indicating that these parasites are probably waterborne pathogens. Ingestion of the environmentally highly resistant spores is probably the normal mode of transmission.

E. bieneusi, an intestinal pathogen, serves as an example of infection potential. The spores are released into the intestinal lumen and are passed in the stool. These spores are environmentally resistant and can be ingested by other hosts. Zoonotic transmission of microsporidia infecting humans has not been verified but appears likely, because many microsporidial species can infect both humans and animals.

Pathogenesis and Spectrum of Disease

Microsporidia were recognized as causing disease in animals as early as the 1920s but were not recognized as agents of human disease until the AIDS pandemic began in the mid-1980s. Before then, several earlier human cases had been reported but were thought to be very unusual.

Enterocytozoon bieneusi

A number of cases of E. bieneusi infection have been reported in patients with AIDS. Chronic intractable diarrhea, fever, malaise, and weight loss are symptoms of E. bieneusi infections, and these symptoms mimic those seen with cryptosporidiosis or isosporiasis. Often these patients have four to eight watery, nonbloody stools each day, accompanied by nausea and anorexia. Dehydration and D-xylose and fat malabsorption also may develop. These patients tend to be severely immunodeficient, with a CD4 count almost always below 200 cells/mm3 and often below 100 cells/mm3. Mixed infections with E. bieneusi and E. intestinalis have also been reported. E. bieneusi infection has been implicated in AIDS-related sclerosing cholangitis. However, demonstration of E. bieneusi spores in extraepithelial tissues does not always appear to be associated with subsequent development of systemic infection.

E. bieneusi spores have been identified in sputum and bronchoalveolar lavage fluid in addition to stool specimens. E. bieneusi can colonize the respiratory tract, and clinical specimens from these specimens may reveal the presence of spores. Multiorgan microsporidiosis caused by E. bieneusi has been diagnosed in patients infected with HIV; organisms have been recovered in stools, duodenal biopsy specimens, nasal discharge, and sputum.

Infection with E. bieneusi has also been reported in immunocompetent individuals; symptoms were self-limited, and diarrheal disease resolved within 2 weeks. E. bieneusi may be more commonly associated with sporadic diarrheal disease than was previously suspected, and the immune system may play a role in the control of this intestinal infection. It is also quite possible that E. bieneusi may persist as an asymptomatic infection in immunocompetent individuals.

Laboratory Diagnosis

The most commonly used stains are chromotrope-based stains (modified trichrome) and chemofluorescent optical brightening agents, including calcofluor white and other chemofluorescent stains. Regardless of the staining technique selected, the use of positive control material is highly recommended. Detection of the small microsporidial spores requires adequate illumination and magnification (i.e., magnification using the oil immersion objective [×100] for a total magnification of ×1000).

Chapter Review

1. Which of the following is the best technique for identifying Dientamoeba fragilis in stool?

2. Which of the following protozoan organisms has been widely implicated in waterborne and food-borne outbreaks in the United States?

3. An Entamoeba histolytica trophozoite has which characteristics?

4. Entamoeba dispar is most easily confused morphologically with:

5. True or False

_____ Microsporidia can cause intestinal symptoms and also disease in other tissues, particularly in immunocompromised patients.

_____ Oocysts of Cryptosporidium spp. can be detected in stool specimens using the modified acid-fast stain.

_____ Fecal immunoassays for antigen detection have become more commonly used to diagnose infections with Dientamoeba fragilis and Blastocystis hominis.

_____ In the United States, sporadic minioutbreaks of diarrheal disease have been associated with the ingestion of strawberries, raspberries, fresh basil, mesclun (baby lettuce leaves), and snow peas. The most likely causative agent is Cryptosporidium spp.

_____ Although the pathogenicity of Blastocystis hominis has been controversial, newer information suggests that numerous strains and species are included in the name, some of which are pathogenic and some nonpathogenic.

6. Matching: Match each term with the corresponding phrase.

image